Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ligand Pharma (LGND)
NASDAQ:LGND
Holding LGND?
Track your performance easily
Ligand Pharma (LGND) Ownership Overview
2.60% Insiders
36.92% Mutual Funds
18.33% Other Institutional Investors
27.68% ETFs
14.47% Public Companies and
Individual Investors
The ownership structure of Ligand Pharma (LGND) stock is a mix of institutional, retail, and individual investors. Approximately 82.93% of the company’s stock is owned by Institutional Investors, 2.60% is owned by Insiders, and 14.47% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 25, 2024 | Andrew Reardon Clo & Secretary | xxxxxxxxxxxxx | $199200 |
| Sep 24, 2024 | Matthew Korenberg President & Coo | xxxxxxxxxxxxx | $1642308 |
| Sep 24, 2024 | xxxxxxxxxxxxx | $132518 | |
| Aug 30, 2024 | Andrew Reardon Clo & Secretary | xxxxxxxxxxxxx | $159585 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $508930 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $667002 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $934106 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $4467380 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,279,003 | Institution | 12.47% | 250,781,490 | |
| 1,777,932 | Institution | 9.73% | 195,643,637 | |
| 1,501,592 | Institution | 8.22% | 165,235,184 | |
| 912,488 | Institution | 4.99% | 100,410,180 | |
| 713,303 | Institution | 3.90% | 78,491,862 | |
| 425,658 | Institution | 2.33% | 46,839,406 | |
| 390,351 | Institution | 2.14% | 42,954,224 | |
| 330,711 | Institution | 1.81% | 36,391,438 | |
| 317,761 | Institution | 1.74% | 34,966,420 | |
| 280,208 | Institution | 1.53% | 30,834,088 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,501,592 | Institution | 8.22% | 165,235,184 | |
| 912,488 | Institution | 4.99% | 100,410,180 | |
| 713,303 | Institution | 3.90% | 78,491,862 | |
| 425,658 | Institution | 2.33% | 46,839,406 | |
| 390,351 | Institution | 2.14% | 42,954,224 | |
| 330,711 | Institution | 1.81% | 36,391,438 | |
| 280,208 | Institution | 1.53% | 30,834,088 | |
| 244,157 | Institution | 1.34% | 26,867,036 | |
| 196,321 | Institution | 1.07% | 21,603,163 | |
| 180,426 | Institution | 0.99% | 19,854,077 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,165,428 | Institution | 6.38% | 128,243,697 | |
| 529,854 | Institution | 2.90% | 53,033,087 | |
| 438,641 | Institution | 2.40% | 48,268,056 | |
| 435,061 | Institution | 2.38% | 43,545,255 | |
| 294,171 | Institution | 1.61% | 29,443,575 | |
| 259,621 | Institution | 1.42% | 25,985,466 | |
| 187,580 | Institution | 1.03% | 20,641,303 | |
| 161,618 | Institution | 0.88% | 17,784,445 | |
| 161,969 | Institution | 0.89% | 17,120,123 | |
| 125,237 | Institution | 0.69% | 13,781,079 |
FAQ
Who Owns Ligand Pharma (LGND)?
According to the latest TipRanks data, approximately 18.33% of the company's stock is held by institutional investors, 2.60% is held by insiders, and 14.47% is held by retail investors.
What percentage of Ligand Pharma (LGND) stock is held by institutional investors?
According to the latest TipRanks data, approximately 18.33% of Ligand Pharma (LGND) stock is held by institutional investors.
What percentage of Ligand Pharma (LGND) stock is held by retail investors?
According to the latest TipRanks data, approximately 14.47% of Ligand Pharma (LGND) stock is held by retail investors.
Who owns the most shares of Ligand Pharma (LGND)?
iShares owns the most shares of Ligand Pharma (LGND).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.